Clinical Trial Update: Signal Detection in Monoclonal and New Agents in Lymphoma

View source ↗

Summary

The clinical trial NCT02849912 examining signal detection related to monoclonal antibodies and new agents in lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Lymphoma | Status: COMPLETED